GLP-1 Telehealth: What Prescribers Need to Know in Texas

If you’re a psychiatrist watching the GLP-1 revolution unfold and wondering whether there’s a place for you in it, here’s the short answer: absolutely. In fact, you might be better positioned than almost anyone else to meet this surge in patient demand.

By 2025, an estimated 6% of Americans—roughly 20 million people—were taking GLP-1 medications like semaglutide (Ozempic/Wegovy) or tirzepatide. That’s a 600% increase in weight-loss usage over just six years. And here’s what most providers miss: this isn’t just about vanity pounds. It’s about a massive, underserved patient population desperate for medical weight management—many of whom already sit in your waiting room.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Prescribing

Let’s start with the elephant in the room: nearly half of psychiatrists were already prescribing or recommending Ozempic and similar drugs as of late 2023. Why? Because weight gain is one of the most frustrating—and sometimes dangerous—side effects of psychiatric medications. Antipsychotics, mood stabilizers, even some SSRIs pack on pounds, and patients frequently abandon treatment because of it.

You already have the clinical relationship. You already understand behavior change, motivation, and the psychological barriers to weight loss. And unlike primary care docs drowning in 15-minute visits, you have the time and skillset to support patients through the mental and physical transformation that GLP-1 therapy requires.

Here’s what makes psychiatric providers different:

• Behavioral health expertise: Weight loss isn’t just about medication—it’s about sustaining motivation, managing emotional eating, and addressing body image issues. You do this every day.
• Existing patient relationships: Many of your patients would benefit from weight management but don’t know you can help with that. A simple conversation during a med check can convert an existing patient into a GLP-1 client.
• Holistic care model: Treating the whole person—mental and physical health together—is what patients actually want. You’re not siloing their care; you’re integrating it.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Business Reality: GLP-1 Patients Are Looking for Providers Right Now

The economics here are straightforward. Demand is exploding, but provider supply hasn’t caught up. Most obesity medicine specialists are booked solid. Primary care doctors lack the bandwidth or expertise to properly manage these patients. That leaves a massive gap—and a genuine opportunity for psychiatrists to step in.

Patient acquisition isn’t the hard part. These patients are actively searching for providers who can prescribe GLP-1s. The challenge is positioning yourself to capture that demand without spending a fortune on marketing.

The Traditional Marketing Trap

Here’s what many solo providers try first: DIY marketing. They invest in SEO, run Google Ads, pay for Psychology Today listings, maybe hire a marketing consultant. The reality? Patient acquisition through these channels typically costs $200-500+ per qualified patient when you factor in:

• Agency or consultant fees ($1,500-5,000/month minimum)
• Google Ads spend (mental health keywords run $15-40+ per click; most clicks don’t convert)
• 6-12 months of SEO investment before you see meaningful traffic
• Staff time handling and qualifying leads
• No-show rates from cold leads
• Failed campaigns and wasted ad spend testing what works

SEO can eventually be cost-effective—if you have the budget, expertise, and patience. But most providers, especially those starting out or scaling, don’t want to gamble $3,000-5,000 monthly on marketing with zero guaranteed ROI.

The Smarter Economic Model: Pay-Per-Appointment Platforms

This is where telehealth platforms like Klarity Health fundamentally change the equation. Instead of paying upfront for uncertain results, you pay only when a qualified patient books with you—similar to how Zocdoc works, but with pre-qualified patients matched to your specialty and availability.

Here’s why this model makes financial sense:

• Zero upfront marketing spend: No monthly subscriptions or retainer fees eating into your revenue before you see a single patient
• Pre-qualified patient flow: Klarity invests in patient acquisition and funnels matched leads to you—patients who specifically need psychiatric weight management
• No wasted ad spend: You’re not paying $30 per click with a 2% conversion rate. You pay a standard listing fee per booked appointment, period.
• Built-in infrastructure: Telehealth platform, billing support, and both insurance and cash-pay patient access included
• You control capacity: Only pay when patients book. Scale up gradually or quickly based on your availability.

The math is simple: instead of spending thousands monthly hoping to acquire patients, you guarantee ROI by paying only for actual appointments. For a psychiatrist adding GLP-1 services, this eliminates the financial risk entirely.

How to Actually Get GLP-1 Patients: Three Proven Strategies

Strategy 1: Start With Your Existing Practice

Your current patient panel likely includes dozens of candidates for GLP-1 therapy. During routine medication reviews:

• Identify patients struggling with medication-induced weight gain. If someone’s gained 30 pounds on Seroquel, bring up GLP-1 as a medical solution—not a cosmetic fix.
• Screen for comorbid obesity. BMI ≥30 (or ≥27 with conditions like diabetes or hypertension) qualifies patients for FDA-approved obesity treatment.
• Address binge eating and emotional eating patterns. Patients with BED or significant emotional overeating often respond well to GLP-1s combined with psychiatric support.

Frame it as comprehensive care: ‘I’m now offering medical weight management as part of our work together. Many of my patients have found this helps them feel better mentally and physically.’ This internal conversion costs you nothing and builds on existing trust.

Strategy 2: Leverage Telehealth Platforms

Joining a reputable GLP-1 telehealth service immediately connects you with high patient volume. Platforms like Klarity, Calibrate, and others invest heavily in advertising and funnel patient inquiries to enrolled providers.

What to look for in a platform:

• Patient quality: Are these people genuinely seeking medical weight management, or just looking for quick cosmetic fixes?
• Prescriber support: Does the platform provide clinical protocols, EHR integration, and compliance guidance?
• Revenue model: Pay-per-appointment beats monthly subscriptions for most providers. You want guaranteed ROI, not fixed overhead.
• Insurance vs cash-pay mix: Platforms that offer both give you more flexibility. Many patients will pay cash if insurance won’t cover the meds.

Strategy 3: Targeted Local and Digital Marketing

If you want to build an independent GLP-1 practice, targeted marketing works—but you need to differentiate yourself:

Position your unique value:

• ‘Psychiatrist specializing in medical weight management for patients with mental health conditions’
• ‘Expert in managing medication-related weight gain with GLP-1 therapy’
• ‘Holistic weight loss combining psychiatric care and obesity medicine’

SEO and content:

• Create educational blog posts: ‘How Antipsychotic Weight Gain Affects Mental Health,’ ‘GLP-1s and Depression: What You Need to Know’
• Optimize for long-tail keywords: ‘psychiatrist prescribing Wegovy [your state],’ ‘mental health and weight loss medication’

Referral relationships:

• Let local PCPs, endocrinologists, and therapists know you offer this service
• Emphasize you’ll coordinate care and refer patients back for routine medical needs
• Therapists dealing with clients’ body image or eating issues are excellent referral sources

Social media:

• Share patient success stories (with consent)
• Educate about the mental health benefits of weight loss
• Address stigma around obesity and medication-assisted treatment

Telehealth GLP-1 Prescribing: Legal and Practical Essentials

Can You Prescribe GLP-1s via Telehealth?

Yes. GLP-1 medications are not controlled substances, which means the federal Ryan Haight Act’s in-person exam requirement doesn’t apply. You can legally prescribe semaglutide, tirzepatide, and other GLP-1 agonists via telemedicine as long as you’re licensed in the patient’s state and meet that state’s standard of care.

Licensure by State: What You Need to Know

For Psychiatrists (MD/DO):You hold full prescriptive authority for GLP-1s in every state. The only requirement is holding a medical license where your patient is located.

Interstate Medical Licensure Compact (IMLC): If you’re licensed in an IMLC member state, you can expedite licensure in other member states (currently 42 states including Texas, Florida, Illinois, Pennsylvania—but NOT California or New York).

For Psychiatric NPs (PMHNPs):State scope-of-practice rules vary significantly:

• California: NPs must work under physician supervision unless they’ve completed 3 years as a ‘103 NP’ (supervised) and qualify for independent ‘104 NP’ status (earliest certifications in 2026). Until then, you need a collaborating psychiatrist.

• Texas: Strict collaborative state. All APRNs need a Prescriptive Authority Agreement with a Texas physician. One MD can supervise up to 7 NPs/PAs.

• Florida: Florida offers out-of-state physicians a special telehealth registration (no full license required) for non-controlled prescribing. However, psychiatric NPs don’t qualify for independent practice—only primary care NPs can achieve autonomous practice after meeting experience requirements.

• New York: NPs with ≥3,600 hours (roughly 2 years) of supervised practice can practice independently. Experienced PMHNPs in NY can prescribe GLP-1s without physician oversight.

• Pennsylvania: Remains fully collaborative. All CRNPs need a physician agreement to prescribe. However, PA joined the IMLC (physicians) and Nurse Licensure Compact (2025), easing multi-state practice logistics.

• Illinois: NPs can achieve Full Practice Authority (FPA) after 4,000 hours of supervised practice plus 250 hours of additional education. FPA-certified PMHNPs can prescribe independently, including controlled substances with some limitations.

Telehealth Standard of Care

Just because you’re prescribing remotely doesn’t mean you can skip steps. Maintain the same standard you would in-person:

• Comprehensive history: Weight history, prior weight loss attempts, medical conditions, contraindications (history of medullary thyroid cancer, pancreatitis), mental health screening
• Baseline labs: A1c, fasting glucose, TSH, liver panel (where appropriate)
• Informed consent: Especially for off-label use (e.g., prescribing Ozempic for weight loss when Wegovy is the FDA-approved brand)
• Document everything: Patient encounters, treatment plans, monitoring, and any adverse events
• State-specific requirements: California requires documented patient consent for telehealth. Texas allows audio-visual consults to establish care. Follow your state’s rules.

Monitor for psychiatric side effects: There were reports in 2023 of rare suicidal ideation possibly linked to GLP-1s. By early 2026, the FDA found no clear causal link and removed suicide warnings, but as a psychiatrist, you should still screen for mood changes during follow-ups—this vigilance is a competitive advantage.

Cash-Pay vs Insurance: Which Model Makes Sense?

Most GLP-1 telehealth practices favor cash-pay models, and here’s why:

The Insurance Reality

While insurers widely cover GLP-1 drugs for diabetes, obesity coverage is limited. As of 2024, only 13 state Medicaid programs (including California and Pennsylvania) covered GLP-1s for weight loss. Many private plans explicitly exclude them, considering obesity treatment ‘not medically necessary.’

Medicare historically didn’t cover weight-loss drugs at all—though pilot programs in late 2025 suggest this may change in coming years.

What this means for your practice:

• Most patients pay out-of-pocket for medications regardless of insurance ($1,300+/month for brand-name Wegovy; $200-400 for compounded semaglutide)
• If you bill insurance for visits, you’ll face prior authorizations, documentation burdens, and potential denials
• Reimbursement rates for obesity counseling are often low

Cash-Pay Advantages

Simplified operations:

• No prior authorizations for appointments
• Direct revenue—patients pay per visit or via monthly subscription
• You control pricing and service scope
• Appeals to patients who want privacy (no insurance records of weight treatment)

Common cash-pay models:

• Initial consult: $150-300
• Follow-up visits: $75-150 per 15-20 minute appointment
• Monthly subscription packages: $200-400 including consultations, coaching, and medication access through partnered pharmacies

Insurance Participation

If you want to widen access or attract patients who can only afford covered visits:

• Bill standard E/M codes for obesity management
• Medicare G0447 code for behavioral counseling (if applicable)
• Document medical necessity (BMI, comorbidities) to support billing

The hybrid approach: Many providers charge cash for the initial comprehensive evaluation (which takes 45-60 minutes and isn’t fully reimbursed by insurance), then bill insurance for follow-ups if the patient has good coverage.

Be transparent with patients: Clearly outline what’s self-pay vs. billed, and help them estimate total monthly costs (meds + visits). Patients appreciate honesty about pricing upfront.

Building a Scalable GLP-1 Practice Without Burning Out

The demand is there. The question is: how do you scale to meet it without destroying your quality of life?

Optimize Your Workflow

Streamline intake:

• Use digital intake forms to gather comprehensive history before the first appointment
• Create standardized ‘Obesity Intake Panels’ for lab orders
• Develop inclusion/exclusion criteria checklists

Standardize protocols:

• Template documentation for initial evaluations and follow-ups
• Dose titration protocols (e.g., start semaglutide at 0.25mg weekly, increase every 4 weeks)
• Side effect management scripts (handling nausea, constipation, injection site issues)

Delegate and Build a Team

You don’t have to do everything:

• Health coaches or RNs can handle lifestyle counseling, weekly check-ins, and non-medication questions
• Medical assistants collect interim weights, blood pressure, and symptom questionnaires before your appointments
• Nutritionists or dietitians provide meal planning support—refer patients or hire part-time

Group visits work: Host monthly telehealth group sessions for weight-loss education and peer support. One 30-minute group Zoom can serve 10-15 patients, reducing repetitive one-on-one counseling.

Leverage Technology

Use tools that save time:

• Integrated telehealth EHRs with e-prescribing and messaging
• Automated appointment reminders and online scheduling
• Remote patient monitoring: issue connected scales or ask patients to report weekly weights via app
• AI-driven chatbots for FAQs (‘Is nausea normal on this dose?’)

Follow-up frequency:

• Monthly for the first 3-6 months during dose titration
• Every 2-3 months once stable
• Brief 15-20 minute virtual check-ins (you can review weight trends and symptom reports beforehand)
• Supplement with asynchronous updates when appropriate

Protect Your Own Well-being

Set boundaries:

• Start with dedicated half-days for GLP-1 patients rather than mixing them into every open slot
• Cap daily consults to prevent overextension
• Establish firm availability hours for patient communication (use delayed email replies or after-hours services)

Maintain professional support:

• Join obesity medicine interest groups or telehealth clinician forums
• Pursue CME or certification in obesity medicine to build confidence and reduce stress
• Consider hiring an NP or PA to share the load as you scale

Monitor yourself for burnout:

• Emotional exhaustion, depersonalization, declining performance = time to reassess workload
• Temporarily cap new patient intakes if needed
• Remember: scaling can mean adding more providers, not just more patients per provider

The bottom line: By combining efficient workflows, team-based care, and proactive self-care, you can grow a GLP-1 practice that serves hundreds of patients without running yourself into the ground.

FAQ: GLP-1 Prescribing for Psychiatrists

Can psychiatrists legally prescribe GLP-1 medications for weight loss?
Yes. Psychiatrists (MD/DO) hold full prescriptive authority for GLP-1 agonists in all states. These are non-controlled substances, so there are no special federal restrictions. You must be licensed in the patient’s state and follow standard medical practice guidelines.

Do I need special training to prescribe GLP-1s?
No formal certification is required, but familiarity with obesity medicine basics is essential: BMI criteria, contraindications (history of medullary thyroid cancer, pancreatitis), managing side effects, and lifestyle counseling. Many psychiatrists pursue CME courses or obesity medicine certification to build expertise and confidence.

Can I prescribe GLP-1s via telehealth without seeing patients in person?
Yes, in most states. Since GLP-1s aren’t controlled substances, the federal Ryan Haight Act’s in-person requirement doesn’t apply. You must establish a valid patient-practitioner relationship via synchronous video (or audio-visual) consultation that meets your state’s standard of care. States like Texas, Florida, and California explicitly allow telehealth-only initiation for non-controlled prescriptions.

What about psychiatric nurse practitioners—can PMHNPs prescribe GLP-1s?
It depends on the state. PMHNPs can prescribe GLP-1s where they have prescriptive authority, but many states require physician collaboration:

• Independent practice: New York (after 3,600 hours), Illinois (after 4,000 hours + education), California (2026 onward for experienced NPs)
• Collaborative practice required: Texas, Florida (for psych NPs), Pennsylvania

How much does it cost to acquire GLP-1 patients through marketing?
DIY marketing (SEO, Google Ads, directories) typically costs $200-500+ per qualified patient when you account for all expenses: ad spend, consultant fees, staff time, no-shows, and months of testing. SEO takes 6-12 months of consistent investment before generating meaningful patient flow. A smarter alternative for most providers is a pay-per-appointment model (like Klarity Health), where you pay only when qualified patients book with you—eliminating upfront risk and wasted spend.

Should I run a cash-pay or insurance-based GLP-1 practice?
Most telehealth GLP-1 practices favor cash-pay because insurance coverage for obesity is limited (many plans exclude weight-loss drugs, and patients often pay out-of-pocket for meds anyway). Cash-pay simplifies operations and generates direct revenue. However, accepting insurance can widen access and attract patients who need covered visits. Many providers use a hybrid model: cash for initial evaluations, insurance for follow-ups if the patient has good coverage.

What’s a realistic patient load for a psychiatrist adding GLP-1 services?
Start conservatively: 10-15 new GLP-1 patients per month alongside your existing psychiatric practice. Each patient requires an initial 45-60 minute evaluation and monthly 15-20 minute follow-ups during dose titration (first 3-6 months). As you optimize workflows and add support staff, you can scale to 50-100+ active weight-management patients while maintaining quality of care and preventing burnout.

What are the most common GLP-1 side effects I need to manage?
Gastrointestinal issues dominate: nausea, vomiting, diarrhea, constipation (usually dose-dependent and improve over time). Instruct patients on slow dose titration, eating smaller meals, and staying hydrated. As a psychiatrist, also monitor mood and anxiety—while the FDA found no clear link between GLP-1s and suicidality, rare reports exist. Screen for mental health changes during every follow-up, especially in patients with psychiatric histories.

Ready to Start? Here’s Your Next Step

The GLP-1 wave isn’t slowing down—patient demand is only increasing. Psychiatrists who position themselves now will capture a market that’s underserved and growing rapidly.

If you’re ready to add medical weight management to your practice without the gamble of expensive upfront marketing, Klarity Health offers a smarter path forward. You get:

• Pre-qualified patients actively seeking psychiatric weight management
• Pay-per-appointment model (no monthly subscriptions or wasted ad spend)
• Built-in telehealth infrastructure and billing support
• Both insurance and cash-pay patient flow
• Complete control over your schedule and capacity

Join Klarity’s provider network and start seeing GLP-1 patients this month—on your terms, at your pace, with guaranteed ROI.

Citations

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage). Published May 27, 2025. Available at: www.axios.com

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry.’ Published October 20, 2025. Available at: www.confectionerynews.com

3. Time – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny.’ Published August 22, 2025. Available at: time.com

4. Axios – ‘America’s doctors need more obesity medicine training.’ Published May 28, 2024. Available at: www.axios.com

5. Axios – ‘States slow to cover GLP-1s for weight loss’ (KFF policy report). Published November 5, 2024. Available at: www.axios.com

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is